September 1, 2014 by
The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study group has now discovered that the risk of this protein does not -- as previously assumed -- depend on its presence within the tumor cell, but rather from its activity in the cells adjacent to the tumor.